Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 6—June 2002
Research

Streptococcus pneumoniae, Brooklyn, New York: Fluoroquinolone Resistance at our Doorstep

John Quale*, David Landman*Comments to Author , Jayashree Ravishankar*, Carlos Flores*, and Simona Bratu*
Author affiliations: *State University of New York Downstate Medical Center, Brooklyn, New York, USA;

Main Article

Table

Antibiotic susceptibility rates of 138 Streptococcus pneumoniae isolates

Antibiotic MIC50 (μg/mL) MIC90 (μg/mL) Range (mg/mL) Susceptible (%) Intermediate (%) Resistant (%)
Penicillin 0.03 2 0.008-4.0 67 16 17
Ceftriaxone 0.015 1 0.004-2.0 87 11 2
Cefepime 0.06 1 0.03-4.0 81 12 7
Meropenem 0.015 0.5 0.004-2.0 82 14 4
Erythromycin 0.125 8 ≤0.015->256.0 75 2 23
Clindamycin 0.125 0.5 0.03->256.0 93 1 6
Ciprofloxacin 2 4 0.5->32.0 34 43 23
Levofloxacin 1 2 0.5->8.0 96.4 2.2 1.4
Chloramphenicol 4 4 ≤ 0.5-64.0 90 10
Linezolid 0.5 1 ≤ 0.125-2.0 100
Quinupristin-dalfopristin 0.5 0.5 0.125-1.0 100

Main Article

Page created: July 16, 2010
Page updated: July 16, 2010
Page reviewed: July 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external